Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.57 |
| ▸ | WNT3A | P56704 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levulinic Acid SCHEMBL4826758 | 0.94 | NR4A2 (0.80) | NR4A2L3MBTL1MAPTLMNATDP1 | |
| P-Xylene SCHEMBL28175467 | 0.90 | KMT2A (0.61) | NR4A2L3MBTL1MAPTLMNATDP1 | |
| SCHEMBL4826769 | 0.89 | NR4A2 (0.55) | NR4A2L3MBTL1MAPTLMNATDP1 | |
| SCHEMBL11686001 | 0.88 | SMN1; SMN2 (0.62) | NR4A2L3MBTL1MAPTLMNATDP1 | |
| SCHEMBL30121738 | 0.88 | NR4A2 (0.85) | NR4A2L3MBTL1MAPTLMNATDP1 | |
| SCHEMBL719034 | 0.88 | NR4A2 (0.85) | NR4A2L3MBTL1MAPTLMNATDP1 | |
| SCHEMBL2632728 | 0.88 | SMN1; SMN2 (0.72) | NR4A2L3MBTL1MAPTLMNASMN1; SMN2 | |
| SCHEMBL8534650 | 0.88 | SMN1; SMN2 (0.72) | NR4A2L3MBTL1MAPTLMNASMN1; SMN2 | |
| SCHEMBL6307346 | 0.87 | TDP1 (0.76) | NR4A2L3MBTL1MAPTLMNATDP1 | |
| SCHEMBL8675031 | 0.87 | TDP1 (0.69) | NR4A2L3MBTL1MAPTLMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111233639-A | Preparation method of 4,4' -dihydroxy diphenyl ether | 甘肃金盾化工有限责任公司 | 2020-06-05 | — | — | CN | claimed |
| CN-110845987-A | High-performance copolyamide hot melt adhesive composition | 南通协鑫热熔胶有限公司 | 2020-02-28 | — | — | CN | claimed |
| CN-107987822-A | High-temperature acidification corrosion inhibitor and preparation method thereof and application | 唐山市金沙工贸有限公司 | 2018-05-04 | — | — | CN | claimed |
| CN-107876092-A | The high stability titanium catalyst of ester exchange carbonate synthesis benzene methyl and diphenyl carbonate | 华东理工大学 | 2018-04-06 | — | — | CN | claimed |
| CN-107417719-A | A kind of titanium chelate catalyst for being used for carbonate synthesis benzene methyl and diphenyl carbonate | 华东理工大学 | 2017-12-01 | — | — | CN | claimed |
| EP-2649102-A1 | POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP | Bridgestone Corporation (JP) | 2013-10-16 | — | — | EP | claimed |
| US-20130079463-A1 | POLYMERS FUNCTIONALIZED WITH POLYHYDRAZONE COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2013-03-28 | — | — | US | claimed |
| WO-2012078962-A1 | POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP | BRIDGESTONE CORPORATION (JP) | 2012-06-14 | — | — | WO | claimed |
| EP-0037062-B1 | SUBSTITUTED 3-ARYL-2-CYCLOALKENE-1-ONES, PROCESS FOR THEIR PREPARATION AND THEIR PARMACEUTICAL USE | Beiersdorf Aktiengesellschaft (DE) | 1984-10-17 | — | — | EP | claimed |
| EP-0037062-A2 | Substituted 3-aryl-2-cycloalkene-1-ones, process for their preparation and their parmaceutical use | Beiersdorf Aktiengesellschaft (DE) | 1981-10-07 | — | — | EP | claimed |
| US-3979482-A | HALOGENATED CARBONYL COMPOUNDS, ULTRAVIOLET RADIATION | Kagiya, Tsutomu (JA) | 1976-09-07 | — | — | US | claimed |
| CN-117342963-A | 1, 4-dicarbonyl compound, and preparation method and application thereof | 上海予君生物科技发展有限公司 | 2024-01-05 | — | — | CN | disclosed |
| US-20230347587-A1 | 3-D PRINTING | PERIDOT PRINT LLC | 2023-11-02 | — | — | US | disclosed |
| US-RE49686-E1 | Nitrogen-containing heterocyclic compound and use of same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-10 | — | — | US | disclosed |
| US-20230016922-A1 | VISIBLE-LIGHT MEDIATED ORGANOPHOTOREDOX CATALYTIC DEUTERATION OF AROMATIC AND ALIPHATIC ALDEHYDES | NATIONAL INSTITUTES OF HEALTH | 2023-01-19 | — | — | US | disclosed |
| US-4071527-A | Certain benzothiazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1978-01-31 | — | — | US | disclosed |
| US-4035395-A | Process for the preparation of ketones | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-12 | — | — | US | disclosed |
| US-4014889-A | Process for preparing ketones | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | disclosed |
| US-4011239-A | MANGANESE, VANADIUM, CERIUM | MOBIL OIL CORPORATION (US) | 1977-03-08 | — | — | US | disclosed |
| US-3979482-A | HALOGENATED CARBONYL COMPOUNDS, ULTRAVIOLET RADIATION | Kagiya, Tsutomu (JA) | 1976-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230016922-A1 | VISIBLE-LIGHT MEDIATED ORGANOPHOTOREDOX CATALYTIC DEUTERATION OF AROMATIC AND ALIPHATIC ALDEHYDES | AOX1, TDO2, TALDO1 | NR4A2 2972/4885L3MBTL1 1594/4885MAPT 3039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.